Specialty Pharma Journal Specialty, Precision & Technology

Sandoz, a Novartis company, is the first company to receive approval of a biosimilar in ...

Australian biotechnology company Novogen Limited’s lead candidate demonstrated promising results in patients with brain cancer. ...

Specialty Pharma Journal (SPJ) today announced the launch of its new name, Specialty Precision & ...

Avella is partnering with technology provider Sentry Data Systems on 340B drug discount program efforts. ...

Japanese pharmaceutical firm Eisai has entered into a clinical trial collaboration to evaluate the combination ...

Today, Arrowhead Research Corporation announced that it has acquired Novartis’ entire RNAi business for $10 ...

AbbVie Inc. announced late Wednesday that it will purchase cancer drugmaker Pharmacyclics for roughly $21 ...

The US Food and Drug Administration (FDA) expanded approval of Bristol-Myers Squibb’s (BMS) Opdivo (nivolumab) ...

Mayo Clinic and Gentag, Inc. have teamed up to develop next-generation, wearable biosensors designed to ...

Baxter International Inc. announced that it has agreed to acquire German biopharmaceutical company SuppreMol, expanding ...

Melanoma patients whose tumors had a specific gene mutation demonstrated better response and treatment outcomes ...

Bristol-Myers Squibb Co. (BMS) said that it has entered into a $1 billion deal with ...

What is professional certification? While there are a wide variety of certifications that span hundreds ...

By Dr. Stephen Vogt Many physicians would likely be surprised to learn that their patients ...

Rare disease maker Alexion Pharmaceuticals has partnered with Blueprint Medicines to develop drugs for a ...